Nutrition
Diet science, supplements, GLP-1s
More nutrition news
- NutritionObesity Drug Development Standards May Be ShiftingA recently published commentary in Nature Medicine suggests that the criteria used to evaluate obesity treatments are undergoing a meaningful reappraisal, a development that could reshape the field broadly.
- NutritionOral GLP-1 Drugs Emerge in Obesity and Diabetes CareA comment published in The Lancet explores the therapeutic potential of oral small-molecule GLP-1 receptor agonists against a backdrop of shifting clinical priorities in obesity and type 2 diabetes management.
- NutritionGLP-1 Microdosing for Weight Loss Draws Safety ConcernsA weight-loss doctor has raised concerns about the growing use of GLP-1 medications in small, so-called microdoses for cosmetic weight loss, warning that long-term safety data for this application remains absent.
- NutritionFarm Bill Caps on Imports Could Remove Bananas From School LunchesProposed caps on imported foods under a new US Farm Bill could see bananas disappear from school cafeterias, with nutrition advocates warning the policy may undermine children's access to healthy, appealing meals.
- NutritionMuscle Loss and Obesity Injections: What Research ShowsA notable proportion of weight lost through obesity injections such as Ozempic may come from muscle rather than fat, experts have warned, prompting efforts to develop a counteracting drug.
- NutritionGLP-1 Drugs and the Brain: What the Evidence ShowsGLP-1 receptor agonists, best known for managing blood sugar and body weight, are being studied across a widening range of conditions — including, tentatively, disorders of the central nervous system.
- NutritionGrief, Nutrition and the Body's Own SignalsWhen one writer lost her husband to asbestos-related lung cancer, then her sister and father in close succession, her path back involved tuning in to what her body was telling her — a response that researchers are beginning to take seriously.
